EP3426284

GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    10.3.2017
  • :
    8.5.2024
  • :
    17710231.6
  • :
    9.3.2037
  • :
    GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS

10.3.2017
8.5.2024
  • :
    MedImmune Limited
  • :
    1 Francis Crick Avenue Cambridge Biomedical Campus, Cambridge CB2 0AA, GB
  • :
    BEDNAREK, Maria, Aleksandra
  • :
    Cambridge Cambridgeshire CB21 6GH, GB
  • :
    JERMUTUS, Lutz, Ulrich
  • :
    Cambridge Cambridgeshire CB21 6GH, GB
  • :
    AMBERY, Philip
  • :
    Cambridge Cambridgeshire CB21 6GH, GB
  • :
    PETRONE, Marcella
  • :
    Cambridge Cambridgeshire CB21 6GH, GB
  • :
    201662306121 P
  • :
    10.3.2016
  • :
    US
  • :
    EP2017055679
  • :
    10.3.2017
  • :
    A61K 38/26, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/12